Wells Fargo’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Buy |
+37,156
| New | +$101K | ﹤0.01% | 4786 |
|
|
2024
Q2 | – | Sell |
-189
| Closed | -$389 | – | 6630 |
|
|
2024
Q1 | $389 | Buy |
189
+3
| +2% | +$6 | ﹤0.01% | 5943 |
|
|
2023
Q4 | $335 | Buy |
186
+14
| +8% | +$25 | ﹤0.01% | 6031 |
|
|
2023
Q3 | $236 | Buy |
172
+26
| +18% | +$36 | ﹤0.01% | 6168 |
|
|
2023
Q2 | $200 | Buy |
146
+60
| +70% | +$82 | ﹤0.01% | 6395 |
|
|
2023
Q1 | $203 | Buy |
86
+2
| +2% | +$5 | ﹤0.01% | 6449 |
|
|
2022
Q4 | $192 | Buy |
84
+2
| +2% | +$5 | ﹤0.01% | 6302 |
|
|
2022
Q3 | $0 | Sell |
82
-10
| -11% | – | ﹤0.01% | 6476 |
|
|
2022
Q2 | $0 | Buy |
92
+4
| +5% | – | ﹤0.01% | 6643 |
|
|
2022
Q1 | $0 | Hold |
88
| – | – | ﹤0.01% | 6781 |
|
|
2021
Q4 | $0 | Hold |
88
| – | – | ﹤0.01% | 6766 |
|
|
2021
Q3 | $1K | Sell |
88
-4
| -4% | -$45 | ﹤0.01% | 6356 |
|
|
2021
Q2 | $1K | Sell |
92
-1
| -1% | -$11 | ﹤0.01% | 6307 |
|
|
2021
Q1 | $1K | Buy |
93
+85
| +1,063% | +$914 | ﹤0.01% | 6335 |
|
|
2020
Q4 | $0 | Buy |
8
+3
| +60% | – | ﹤0.01% | 6214 |
|
|
2020
Q3 | $0 | Buy |
5
+1
| +25% | – | ﹤0.01% | 6046 |
|
|
2020
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 5979 |
|
|
2020
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 5946 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 5833 |
|
|
2016
Q2 | – | Sell |
-2
| Closed | -$1K | – | 5806 |
|
|
2016
Q1 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 5814 |
|
|
2015
Q4 | – | Hold |
0
| – | -$1K | – | 5917 |
|
|
2015
Q3 | – | Sell |
-3
| Closed | -$6K | – | 5750 |
|
|
2015
Q2 | $6K | Sell |
3
-3
| -50% | -$6K | ﹤0.01% | 5693 |
|
|
2015
Q1 | $11K | Buy |
+6
| New | +$11K | ﹤0.01% | 5379 |
|